Patricia Poon

Biography

Dr. Patricia Poon is a specialist in Clinical Oncology. She graduated from the University of Adelaide, South Australia in 1995. She subsequently received her oncology training at the Queen Elizabeth Hospital in Hong Kong and became a fellow of the Royal College of Radiologists in 2002. Dr. Poon earned the Fellowship of Hong Kong College of Radiologists and Fellowship of the Hong Kong Academy of Medicine (Radiology) in 2005. She also obtained a Master degree in Palliative Medicine at the Cardiff University, U.K. in 2010.

Besides training at the Queen Elizabeth Hospital in Hong Kong, she was the Consultant Oncologist at the Hong Kong Baptist Hospital until 2014. She is currently working as a private Clinical Oncologist in Hong Kong.

Dr. Poon had vast experience in cancer researches especially in the field of lung cancer and palliative care, and was heavily involved in development of cancer treatment protocols and in organization of oncology scientific activities in Hong Kong. She had been the invited speaker in numerous local and overseas oncology conferences. Dr. Poon was appointed as a member of the Radiation Board of the Hong Kong SAR government since 2014. She is currently focused on clinical management of breast cancer patients in Hong Kong.

Abstract

Breast cancer (BC) is the most common malignancy in women and a leading cause of death in a majority of countries in the world. Globally, approximately 1.7 million cases of BC were incident in 2016, and the condition – which affects young women especially – results in a high burden of disease with an estimated 14.3 million years of life lost through 545, 000 deaths in 2016 alone. In Hong Kong, 26.6% of all cancers in women are BC, and it is the third-highest cause of cancer deaths. The prognosis of BC depends on staging and subtype, primarily the presence (+) of hormone receptors for oestrogen or progesterone and the overexpression of human epidermal growth factor receptor 2 (HER2). Overall, the prognosis and survival of breast cancer patients had been improving owing to the plethora of researches on novel treatment strategies over the past years.

In this lecture, latest research results and most current treatment guidelines on various breast cancer subtypes will be presented.

Share This Speaker
Speaker Details
  • Location
  • AFFILIATION OF THE SPEAKER
    Hong Kong Lung Cancer Study Group
Breast Cancer Management: Hong Kong perspective

8th November 2020,18:00pm

Events of the Speaker
You might also love these events.
Past
November 7, 2020
The highlights for the 7th HKIOS include application of artificial intelligence in radiotherapy planning and biomarkers discovery, ultra-high dose rate (FLASH) radiotherapy and alternating electric fields (tumour treating fields or TTF). Many oncologists are not familiar with these brand-new modalities, which are being slowly incorporated into our clinical practice. Due to Covid-19 pandemic, we shall conduct our symposium virtually. We thank our local and overseas speakers for their stern support and contribution again.